# DFFA

## Overview
The DFFA gene encodes the DNA fragmentation factor subunit alpha (DFF45), a crucial regulatory protein involved in the apoptotic pathway. DFF45 functions primarily as an inhibitor and chaperone for the DNA fragmentation factor subunit beta (DFF40), a DNase responsible for executing DNA fragmentation during apoptosis. This protein is categorized as a regulatory protein due to its role in modulating the activity of DFF40. In non-apoptotic cells, DFF45 binds to DFF40, maintaining the complex in an inactive state to prevent premature DNA fragmentation. Upon apoptotic signaling, DFF45 is cleaved by caspase-3, releasing DFF40 to initiate DNA fragmentation, a key step in programmed cell death. The regulation of DFFA is essential for cellular homeostasis, and its dysregulation is associated with pathological conditions such as cancer and autoimmune disorders (Eckhart2007Phylogenomics; Abel2002Analyses; Fawzy2017Evaluation).

## Structure
The DFFA gene encodes the DFF45 protein, which is a component of the DNA Fragmentation Factor (DFF), a heterodimeric protein composed of DFF40 and DFF45 subunits. DFF45, also known as ICAD (Inhibitor of CAD), functions as an inhibitor of DFF40, a DNase responsible for DNA fragmentation during apoptosis (Abel2002Analyses). The N-terminal domain (NTD) of DFF45, comprising residues 12-100, is unstructured in solution but folds upon binding to the NTD of DFF40, forming a complex with an α/β-roll fold. This structure consists of five β-strands arranged into a single β-sheet with helices packed against it, similar to the NTD of CIDE-B (Zhou2001Solution).

The interaction between DFF40 and DFF45 involves specific hydrophobic contacts, such as Ala-22/Tyr-75, Val-21/Val-70, and Phe-19/Ile-69, which are crucial for the quaternary structure and the formation of active nucleases during apoptosis (Abel2002Analyses). DFF45 contains two caspase-3 recognition sites at amino acid positions 117 and 224, which are important for its role in apoptosis (Abel2002Analyses). The full-length DFF45 functions as a chaperone for DFF40, indicating that the amino acids from 261 to 331 are relevant for its function (Abel2002Analyses).

## Function
The DFFA gene encodes the DFF45 protein, which plays a crucial role in the regulation of apoptosis, a process of programmed cell death. In healthy human cells, DFF45 functions as a chaperone for DFF40, the enzymatically active component of the DNA fragmentation factor (DFF) complex. DFF45 binds to DFF40, inhibiting its activity and keeping the DFF complex in an inactive state to prevent unwanted DNA fragmentation (Abel2002Analyses; Eckhart2007Phylogenomics). This inhibition is essential for maintaining cellular integrity and preventing premature cell death.

During apoptosis, DFF45 is cleaved by caspase-3, releasing the active DFF40, which then induces DNA fragmentation and chromatin condensation, key steps in the execution phase of apoptosis (Eckhart2007Phylogenomics; Fawzy2017Evaluation). The proper regulation of DFFA is vital for normal cellular processes, as its dysregulation can lead to pathological conditions, including cancer (Fawzy2017Evaluation). DFF45 is primarily active in the nucleus, where it interacts with DFF40 to control DNA fragmentation during apoptosis (Fawzy2017Evaluation). This regulatory mechanism underscores the importance of DFFA in maintaining cellular homeostasis and its potential role in tumor suppression (Abel2002Analyses).

## Clinical Significance
Mutations or alterations in the expression of the DFFA gene, which encodes the DNA fragmentation factor subunit alpha, have significant clinical implications. DFFA is involved in apoptosis, a critical process for maintaining cellular homeostasis. Deficiencies in DFF, which includes DFFA, can lead to increased mutations and chromosomal instability, contributing to tumorigenesis. This is particularly evident in the context of cancer, where human tumors often exhibit mutations or abnormal expression levels of DFF genes, including DFFA, which are linked to various cancer types (Widlak2008Roles).

In addition to its role in cancer, DFFA is implicated in systemic lupus erythematosus (SLE). Studies in DFF null mice have shown reduced antibody production to nuclear components, suggesting a potential link between DFFA deficiency and SLE susceptibility (Widlak2008Roles). Furthermore, DFFA's involvement in chromosomal translocations can lead to mixed lineage leukemias, highlighting its dual role in both promoting and preventing disease depending on its expression and regulation (Widlak2008Roles).

Overall, the dysregulation of DFFA can lead to impaired apoptosis, contributing to the development and progression of various diseases, including cancer and autoimmune disorders.

## Interactions
DFFA, also known as DNA fragmentation factor subunit alpha, interacts with DFFB (DNA fragmentation factor subunit beta) to form a complex that is crucial for DNA fragmentation during apoptosis. This interaction is mediated by their amino-terminal CIDE-N domains, where DFFA functions as a folding chaperone for DFFB, ensuring its proper expression and stability (Eckhart2007Phylogenomics). In non-apoptotic cells, DFFA binds to and inhibits DFFB, maintaining the complex in an inactive state. Upon apoptotic signaling, DFFA is cleaved by caspase-3, which releases DFFB to become active and execute DNA fragmentation (Eckhart2007Phylogenomics).

DFFA also interacts with caspase-3, which cleaves it at specific sites, a process necessary for the activation of DFFB and subsequent DNA fragmentation (Eckhart2007Phylogenomics). A rare polymorphism in DFFA can affect its interaction with DFFB by altering hydrophobic interactions between their N-terminal domains, potentially leading to inactive nucleases during apoptosis (Abel2002Analyses). These interactions highlight the regulatory role of DFFA in apoptosis, ensuring that DNA fragmentation occurs in a controlled manner.


## References


[1. (Abel2002Analyses) F Abel, R-M Sjöberg, K Ejeskär, C Krona, and T Martinsson. Analyses of apoptotic regulators casp9 and dffa at 1p36.2, reveal rare allele variants in human neuroblastoma tumours. British Journal of Cancer, 86(4):596–604, February 2002. URL: http://dx.doi.org/10.1038/sj.bjc.6600111, doi:10.1038/sj.bjc.6600111. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.bjc.6600111)

[2. (Eckhart2007Phylogenomics) Leopold Eckhart, Heinz Fischer, and Erwin Tschachler. Phylogenomics of caspase-activated dna fragmentation factor. Biochemical and Biophysical Research Communications, 356(1):293–299, April 2007. URL: http://dx.doi.org/10.1016/j.bbrc.2007.02.122, doi:10.1016/j.bbrc.2007.02.122. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2007.02.122)

[3. (Widlak2008Roles) P. Widlak and W. T. Garrard. Roles of the major apoptotic nuclease-dna fragmentation factor-in biology and disease. Cellular and Molecular Life Sciences, 66(2):263–274, September 2008. URL: http://dx.doi.org/10.1007/s00018-008-8472-9, doi:10.1007/s00018-008-8472-9. This article has 62 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-008-8472-9)

[4. (Zhou2001Solution) Pei Zhou, Alexey A. Lugovskoy, John S. McCarty, Peng Li, and Gerhard Wagner. Solution structure of dff40 and dff45 n-terminal domain complex and mutual chaperone activity of dff40 and dff45. Proceedings of the National Academy of Sciences, 98(11):6051–6055, May 2001. URL: http://dx.doi.org/10.1073/pnas.111145098, doi:10.1073/pnas.111145098. This article has 113 citations.](https://doi.org/10.1073/pnas.111145098)

[5. (Fawzy2017Evaluation) Manal S. Fawzy, Eman A. Toraih, Afaf Ibrahiem, Hala Abdeldayem, Amany O. Mohamed, and Mohamed M. Abdel-Daim. Evaluation of mirna-196a2 and apoptosis-related target genes: anxa1, dffa and pdcd4 expression in gastrointestinal cancer patients: a pilot study. PLOS ONE, 12(11):e0187310, November 2017. URL: http://dx.doi.org/10.1371/journal.pone.0187310, doi:10.1371/journal.pone.0187310. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0187310)